CDH2 and melanoma: These regulators include MAPK signaling pathway indicators p-BRAF and p-ERK, metastatic markers N-Cadherin and Vimentin, proliferative marker PCNA, and melanoma-specific transcription factor SOX10 (S6I Fig).